Skip to main content

Advertisement

SpringerLink
Log in

Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fatourou E, Macheras A, Misiakos EP, Liakakos T. Perioperative chemotherapy for gastric cancer. Ann Surg Oncol. 2009;16:226–7.

    Article  PubMed  CAS  Google Scholar 

  2. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993;218:583–92.

    Article  PubMed  CAS  Google Scholar 

  3. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–42.

    Article  PubMed  CAS  Google Scholar 

  4. Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol. 2005;23:6220–32.

    Article  PubMed  CAS  Google Scholar 

  5. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.

    Article  PubMed  CAS  Google Scholar 

  6. Ajani JA, Ota DM, Jessup JM, Ames FC, McBride C, Boddie A, et al. Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer. 1991;68:1501–6.

    Article  PubMed  CAS  Google Scholar 

  7. Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, et al. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst. 1993;85:1839–44.

    Article  PubMed  CAS  Google Scholar 

  8. Fink U, Schuhmacher C, Stein HJ, Busch R, Feussner H, Dittler HJ, et al. Preoperative chemotherapy for stage III–IV gastric carcinoma: feasibility, response and outcome after complete resection. Br J Surg. 1995;82:1248–52.

    Article  PubMed  CAS  Google Scholar 

  9. Crookes P, Leichman CG, Leichman L, Tan M, Laine L, Stain S, et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer. 1997;79:1767–75.

    Article  PubMed  CAS  Google Scholar 

  10. Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, et al. Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. J Clin Oncol. 1999;17:2403–11.

    PubMed  CAS  Google Scholar 

  11. Schuhmacher CP, Fink U, Becker K, Busch R, Dittler HJ, Mueller J, et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer. 2001;91:918–27.

    Article  PubMed  CAS  Google Scholar 

  12. Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, Kranenbarg EK, et al. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol. 2004;30:643–9.

    Article  PubMed  CAS  Google Scholar 

  13. Barone C, Cassano A, Pozzo C, D’Ugo D, Schinzari G, Persiani R, et al. Long term follow up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer. Oncology. 2004;67:48–53.

    Article  PubMed  CAS  Google Scholar 

  14. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

    Article  PubMed  CAS  Google Scholar 

  15. D’Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240:808–16.

    Article  PubMed  Google Scholar 

  16. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247–55.

    Article  PubMed  Google Scholar 

  17. D’Ugo DM, Coppola R, Persiani R, Ronconi P, Caracciolo F, Picciocchi A. Immediately preoperative laparoscopic staging for gastric cancer. Surg Endosc. 1996;10:996–9.

    Article  PubMed  CAS  Google Scholar 

  18. D’Ugo DM, Pende V, Persiani R, Rausei S, Picciocchi A. Laparoscopic staging of gastric cancer: an overview. J Am Coll Surg. 2003;196:965–74.

    Article  PubMed  Google Scholar 

  19. Harewood GC. Treatment of gastric cancer. N Engl J Med. 2006;355:1386.

    Article  PubMed  CAS  Google Scholar 

  20. D’Ugo D, Persiani R, Rausei S, Biondi A, Vigorita V, Boccia S, et al. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer. Eur J Surg Oncol. 2006;32:1105–9.

    Article  PubMed  CAS  Google Scholar 

  21. Becker K, Mueller JD, Schuhmacher C, Ott K, Fink U, Busch R, et al. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer. 2003;98:1521–30.

    Article  PubMed  Google Scholar 

  22. Persiani R, D’Ugo D, Rausei S, Sermoneta D, Barone C, Pozzo C, et al. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. J Surg Oncol. 2005;89:227–36.

    Article  PubMed  Google Scholar 

  23. Yonemura Y, Kinoshita K, Fujimura T, Fushida S, Sawa T, Matsuki N, et al. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. Hepatogastroenterology. 1996;43:1260–72.

    PubMed  CAS  Google Scholar 

  24. Waters JS, Norman A, Cunningham D, Scarffe JH, Webb A, Harper P, et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer. 1999;80:269–72.

    Article  PubMed  CAS  Google Scholar 

  25. Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouché O, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol. 2007;25:4510.

    Google Scholar 

  26. Mansour JC, Coit D. Appropriate treatment for patients with gastric cancer (author reply). Ann Surg Oncol. 2008;15:1798–9.

    Article  Google Scholar 

  27. Persiani R, Rausei S, Pozzo C, Biondi A, Barone C, Cananzi FC, et al. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study. Ann Surg Oncol. 2008;15:2146–52.

    Article  PubMed  Google Scholar 

  28. Lordick F, Ott K, Krause BJ, Becker K, Stein HJ, Lorenzen S, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 2007;8:797–805.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, 1st Surgical Division, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy

    Roberto Persiani MD, Stefano Rausei MD, Alberto Biondi MD & Domenico D’Ugo FACS

Authors
  1. Roberto Persiani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Rausei MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alberto Biondi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Domenico D’Ugo FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Persiani MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persiani, R., Rausei, S., Biondi, A. et al. Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?. Ann Surg Oncol 16, 1077–1079 (2009). https://doi.org/10.1245/s10434-008-0310-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0310-7

Keywords

Search

Navigation